Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SATRALIZUMAB vs SCOPOLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SATRALIZUMAB vs SCOPOLAMINE: Safety Overview

Metric SATRALIZUMAB SCOPOLAMINE
Total FAERS Reports 219 2,747
Deaths Reported 16 219
Death Rate 7.3% 8.0%
Hospitalizations 108 497
Average Patient Age 51.6 yrs 49.3 yrs
% Female Patients 82.1% 70.8%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Genentech, Inc. Bryant Ranch Prepack
Route SUBCUTANEOUS TRANSDERMAL
Marketing Status Prescription Prescription